These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 2028453)
1. A sulfated rabbit endothelial cell glycoprotein that inhibits factor VIIa/tissue factor is functionally and immunologically identical to rabbit extrinsic pathway inhibitor (EPI). Warn-Cramer BJ; Maki SL; Rapaport SI Thromb Res; 1991 Mar; 61(5-6):515-27. PubMed ID: 2028453 [TBL] [Abstract][Full Text] [Related]
2. Extrinsic pathway inhibitor--the key to feedback control of blood coagulation initiated by tissue thromboplastin. Sandset PM; Abildgaard U Haemostasis; 1991; 21(4):219-39. PubMed ID: 1794748 [TBL] [Abstract][Full Text] [Related]
3. Enhanced inhibition of tissue factor by the extended form of an endothelial cell glycoprotein (an extrinsic pathway inhibitor). Colburn P; Crabb JW; Buonassisi V J Cell Physiol; 1991 Aug; 148(2):320-6. PubMed ID: 1880157 [TBL] [Abstract][Full Text] [Related]
4. Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions. Pedersen AH; Nordfang O; Norris F; Wiberg FC; Christensen PM; Moeller KB; Meidahl-Pedersen J; Beck TC; Norris K; Hedner U J Biol Chem; 1990 Oct; 265(28):16786-93. PubMed ID: 2211593 [TBL] [Abstract][Full Text] [Related]
5. Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: evidence supporting a physiologic role for EPI as a natural anticoagulant. Sandset PM; Warn-Cramer BJ; Rao LV; Maki SL; Rapaport SI Proc Natl Acad Sci U S A; 1991 Feb; 88(3):708-12. PubMed ID: 1899482 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of binding of recombinant extrinsic pathway inhibitor (rEPI) to cultured cell surfaces. Evidence that rEPI can bind to and inhibit factor VIIa-tissue factor complexes in the absence of factor Xa. Callander NS; Rao LV; Nordfang O; Sandset PM; Warn-Cramer B; Rapaport SI J Biol Chem; 1992 Jan; 267(2):876-82. PubMed ID: 1730676 [TBL] [Abstract][Full Text] [Related]
7. A sensitive, accurate assay for extrinsic pathway inhibitor (EPI) activity in rabbit plasma: paradoxical effect of excess exogenous factor X. Warr TA; Rao LV; Rapaport SI Thromb Res; 1990 Aug; 59(4):773-82. PubMed ID: 2080494 [TBL] [Abstract][Full Text] [Related]
8. Studies of the factor Xa-dependent inhibitor of factor VIIa/tissue factor (extrinsic pathway inhibitor) from cell supernates of cultured human umbilical vein endothelial cells. Warn-Cramer BJ; Almus FE; Rapaport SI Thromb Haemost; 1989 Feb; 61(1):101-5. PubMed ID: 2665164 [TBL] [Abstract][Full Text] [Related]
9. Functional properties of factor VIIa/tissue factor formed with purified tissue factor and with tissue factor expressed on cultured endothelial cells. Almus FE; Rao LV; Rapaport SI Thromb Haemost; 1989 Dec; 62(4):1067-73. PubMed ID: 2617454 [TBL] [Abstract][Full Text] [Related]
10. Evidence that plasma lipoproteins inhibit the factor VIIa-tissue factor complex by a different mechanism that extrinsic pathway inhibitor. Kondo S; Kisiel W Blood; 1987 Dec; 70(6):1947-54. PubMed ID: 3315045 [TBL] [Abstract][Full Text] [Related]
11. Partial purification and characterization of extrinsic pathway inhibitor (the factor Xa-dependent plasma inhibitor of factor VIIa/tissue factor). Warn-Cramer BJ; Maki SL; Zivelin A; Rapaport SI Thromb Res; 1987 Oct; 48(1):11-22. PubMed ID: 3501173 [TBL] [Abstract][Full Text] [Related]
12. Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation. Rao LV; Rapaport SI Blood; 1987 Feb; 69(2):645-51. PubMed ID: 3492226 [TBL] [Abstract][Full Text] [Related]
13. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action. Broze GJ; Warren LA; Novotny WF; Higuchi DA; Girard JJ; Miletich JP Blood; 1988 Feb; 71(2):335-43. PubMed ID: 3422166 [TBL] [Abstract][Full Text] [Related]
15. Extrinsic pathway inhibitor (EPI) released to the blood by heparin is a more powerful coagulation inhibitor than is recombinant EPI. Lindahl AK; Abildgaard U; Larsen ML; Staalesen R; Hammer AK; Sandset PM; Nordfang O; Beck TC Thromb Res; 1991 Jun; 62(6):607-14. PubMed ID: 1926055 [TBL] [Abstract][Full Text] [Related]
16. Chromogenic substrate assay of extrinsic pathway inhibitor (EPI): levels in the normal population and relation to cholesterol. Sandset PM; Larsen ML; Abildgaard U; Lindahl AK; Odegaard OR Blood Coagul Fibrinolysis; 1991 Jun; 2(3):425-33. PubMed ID: 1932528 [TBL] [Abstract][Full Text] [Related]
17. The anticoagulant effect in heparinized blood and plasma resulting from interactions with extrinsic pathway inhibitor. Lindahl AK; Abildgaard U; Staalesen R Thromb Res; 1991 Oct; 64(2):155-68. PubMed ID: 1811336 [TBL] [Abstract][Full Text] [Related]
18. Activation of factor X and its regulation by tissue factor pathway inhibitor in small-diameter capillaries lined with human endothelial cells. Lindhout T; Blezer R; Schoen P; Nordfang O; Reutelingsperger C; Hemker HC Blood; 1992 Jun; 79(11):2909-16. PubMed ID: 1586738 [TBL] [Abstract][Full Text] [Related]
19. Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor.VIIa with Xa.tissue factor pathway inhibitor. Rao LV; Ruf W Biochemistry; 1995 Aug; 34(34):10867-71. PubMed ID: 7662667 [TBL] [Abstract][Full Text] [Related]